RSS

BNTX BioNTech SE

Last Post: 03/09/22
Followers: 0
Posts Today: 0
Views Today: 34

BNTX Stock Quote & Tools

$91.7000 ▼ -4.2500 (-4.43%) As of Jun 1, 4:00 PM EDT
Last91.7000
$ Chg-4.2500
Open97.0000
High97.4400
Beta1.3253
Year High124.000
Market Cap23.05B
P/B Ratio1.06
EPS-5.52
Avg Vol (30d)976.7K
Volume1.30M
% Chg-4.43%
Prev Close95.9500
Low91.2600
VWAP92.30898
Year Low79.520
Total Shares251.33M
Shares Out251.33M
Float208.35M
ExchangeNGS
Healthcare Biotechnology & Life Sciences

BNTX Stock Message Board Discussion

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Urged to Explore Rights in Symbotic Class Action

Updated Category News Views 77

Understanding the Class Action Lawsuit for Symbotic Inc. Investors in Symbotic Inc. (NASDAQ:SYM) are currently facing significant concerns regarding recent developments within the company. A class action lawsuit has been initiated in the U.S. District Court for the District of Massachusetts, aimed at those investors who purchased securities between the specified dates....

Continue Reading
Egypt's President Sisi Reflects on IMF Agreement Amid Crisis

Updated Category News Views 169

Egypt's Economic Landscape Under Scrutiny In light of unprecedented regional challenges, Egyptian President Abdel Fattah al-Sisi has raised concerns regarding the nation's ongoing agreement with the International Monetary Fund (IMF). The $8 billion financial support program, signed amidst economic turbulence, may be revisited if the expectations of global financial...

Continue Reading
Insights into Mastercard's Recent Options Trading Dynamics

Updated Category News Views 102

Mastercard's Options Activity: What's Happening? Recently, the options market has seen significant movement from large investors, commonly referred to as "whales." This activity indicates a largely bearish sentiment towards Mastercard. In our analysis of the recent trades involving Mastercard MA, we identified eight significant transactions. Interestingly, none of these...

Continue Reading
Coave Therapeutics Raises Significant Funding for Genetic Breakthroughs

Updated Category News Views 292

Coave Therapeutics Secures Major Investment to Propel Innovation Coave Therapeutics, a pioneer in the realm of genetic medicines, has successfully raised €32 million (approximately $33 million) in a Series A financing round. This funding was notably co-led by Novo Holdings A/S and Bpifrance, with additional contributions from leading investors in the US and EU,...

Continue Reading
Strive Expands with MSTR True North Acquisition and Leadership Change

Updated Category News Views 140

Strive's Exciting Acquisition of MSTR True North Inc. Strive, Inc. has made waves in the financial technology sector with its strategic acquisition of MSTR True North Inc. This move marks a pivotal moment in Strive's journey, enhancing its commitment to Bitcoin advocacy and marking a significant step forward in the realm of Digital Capital and Digital Credit. Leadership...

Continue Reading